1. Effects and risk factors of TAS-102 in real-world patients with metastatic colorectal cancer, EROTAS-R study
   Naohisa Yoshida et al, 2023, International Journal of Clinical Oncology CrossRef
2. Biomarkers of Trifluridine-Tipiracil Efficacy
   Ioannis A. Voutsadakis, 2021, Journal of Clinical Medicine CrossRef
3. A Systematic Review and Meta-Analysis of Trifluridine/Tipiracil plus Bevacizumab for the Treatment of Metastatic Colorectal Cancer: Evidence from Real-World Series
   Ioannis A. Voutsadakis, 2023, Current Oncology CrossRef
4. Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy
   Julien Taieb et al, 2023, BMC Cancer CrossRef
5. Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias
   Daichi Watanabe et al, 2023, BMC Cancer CrossRef